Prostaglandin E2–EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion (original) (raw)

• Steinman, L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage. Nat. Med. 13, 139–145 (2007).
  Article CAS PubMed Google Scholar
• Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V.K. IL-17 and TH17 cells. Annu. Rev. Immunol. 27, 485–517 (2009).
  Article CAS PubMed Google Scholar
• Steinman, L. A rush to judgment on TH17. J. Exp. Med. 205, 1517–1522 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Bouma, G. & Strober, W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3, 521–533 (2003).
  Article CAS PubMed Google Scholar
• Lowes, M.A., Bowcock, A.M. & Krueger, J.G. Pathogenesis and therapy of psoriasis. Nature 445, 866–873 (2007).
  Article CAS PubMed Google Scholar
• Lock, C. et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500–508 (2002).
  Article CAS PubMed Google Scholar
• Tzartos, J.S. et al. Interleukin-17 produciton in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172, 146–155 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Moldovan, I.R. et al. Interferon γ responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression. J. Neuroimmunol. 141, 132–140 (2003).
  Article CAS PubMed Google Scholar
• Fassbender, K. et al. Increased release of interleukin-12p40 in MS: association with intracerebral inflammation. Neurology 51, 753–758 (1998).
  Article CAS PubMed Google Scholar
• Ziolkowska, M. et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A–sensitive mechanism. J. Immunol. 164, 2832–2838 (2000).
  Article CAS PubMed Google Scholar
• Fujino, S. et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52, 65–70 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Annunziato, F. et al. Phenotypic and functional feature of human TH17 cells. J. Exp. Med. 204, 1849–1861 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Lowes, M.A. et al. Psoriasis vulgaris lesions contain discrete populations of TH1 and TH17 T cells. J. Invest. Dermatol. 128, 1207–1211 (2008).
  Article CAS PubMed Google Scholar
• Duerr, R.H. et al. A genome-wide association study identifies IL-23R as an inflammatory bowel disease gene. Science 314, 1461–1463 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Xavier, R.J. & Podolsky, D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427–434 (2007).
  Article CAS PubMed Google Scholar
• Capon, F. et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum. Genet. 122, 201–206 (2007).
  Article CAS PubMed Google Scholar
• Mannon, P.J. et al. Anti–interleukin-12 antibody for active Crohn's disease. N. Engl. J. Med. 351, 2069–2079 (2004).
  Article CAS PubMed Google Scholar
• Krueger, G.G. et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N. Engl. J. Med. 356, 580–592 (2007).
  Article CAS PubMed Google Scholar
• Narumiya, S. Physiology and pathophysiology of prostanoid receptors. Proc. Japan Acad. Ser. B. 83, 296–319 (2007).
  Article CAS Google Scholar
• Goodwin, J.S. & Ceuppens, J. Regulation of the immune response by prostaglandins. J. Clin. Immunol. 3, 295–315 (1983).
  Article CAS PubMed Google Scholar
• Hasler, F., Bluestein, H.G., Zvaifler, N.J. & Epstein, L.B. Analysis of the defects responsible for the impaired regulation of EBV-induced B cell proliferation by rheumatoid arthritis lymphocytes. II. Role of monocytes and the increased sensitivity of rheumatoid arthritis lymphocytes to prostaglandin E. J. Immunol. 131, 768–772 (1983).
  CAS PubMed Google Scholar
• Betz, M. & Fox, B.S. Prostaglandin E2 inhibits production of TH1 lymphokines but not of Th2 lymphokines. J. Immunol. 146, 108–113 (1991).
  CAS PubMed Google Scholar
• Gold, K.N., Weyand, C.M. & Goronzy, J.J. Modulation of helper T cell function by prostaglandins. Arthritis Rheum. 37, 925–933 (1994).
  Article CAS PubMed Google Scholar
• Hilkens, C.M. et al. Differential modulation of T helper type 1 (TH1) and T helper type 2 (TH2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur. J. Immunol. 25, 59–63 (1995).
  Article CAS PubMed Google Scholar
• Harris, S.G., Padilla, J., Koumas, L., Ray, D. & Phipps, R.P. Prostaglandins as modulators of immunity. Trends Immunol. 23, 144–150 (2002).
  Article CAS PubMed Google Scholar
• Sugimoto, Y. & Narumiya, S. Prostaglandin E receptors. J. Biol. Chem. 282, 11613–11617 (2007).
  Article CAS PubMed Google Scholar
• Nataraj, C. et al. Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse. J. Clin. Invest. 108, 1229–1235 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Mustelin, T. & Tasken, K. Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem. J. 371, 15–27 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Chemnitz, J.M. et al. Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphoma. Cancer Res. 66, 1114–1122 (2006).
  Article CAS PubMed Google Scholar
• Suzawa, T. et al. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3 and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 141, 1554–1559 (2000).
  Article CAS PubMed Google Scholar
• Narumiya, S. & FiztGerald, G.A. Genetic and pharmacological analysis of prostanoid receptor function. J. Clin. Invest. 108, 25–30 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Kabashima, K. et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J. Clin. Invest. 109, 883–893 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Segi, E. et al. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4–deficient mice. Biochem. Biophys. Res. Commun. 246, 7–12 (1998).
  Article CAS PubMed Google Scholar
• Hizaki, H. et al. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP2 . Proc. Natl. Acad. Sci. USA 96, 10501–10506 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Christensen, A.E. et al. cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J. Biol. Chem. 278, 35394–35402 (2003).
  Article CAS PubMed Google Scholar
• Murray, A.J. Pharmacological PKA inhibition: all may not be what it seems. Sci. Signal. 1, re4 (2008).
  Article PubMed Google Scholar
• Carpenter, C.L. & Cantley, L.C. Phosphoinositide kinases. Curr. Opin. Cell Biol. 8, 153–158 (1996).
  Article CAS PubMed Google Scholar
• Buchanan, F.G. et al. Role of β-arrestin 1 in the metastatic progression of colorectal cancer. Proc. Natl. Acad. Sci. USA 103, 1492–1497 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Regan, J.W. EP2 and EP4 prostanoid receptor signaling. Life Sci. 74, 143–153 (2003).
  Article CAS PubMed Google Scholar
• Okkenhaug, K. & Vanhaesebroeck, B. PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3, 317–330 (2003).
  Article CAS PubMed Google Scholar
• Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233–240 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, Y.K. et al. Late developmental plasticity in the T helper 17 lineage. Immunity 30, 92–107 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Nurieva, R., Yang, X.O., Chung, Y. & Dong, C. Cutting edge: In vitro generated TH17 cells maintain their cytokine expression program in normal but not lymphopenic hosts. J. Immunol. 182, 2565–2568 (2009).
  Article CAS PubMed Google Scholar
• Nakae, S. et al. Antigen-specific T cell sensitization is impaired in IL-17–deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17, 375–387 (2002).
  Article CAS PubMed Google Scholar
• Serada, S. et al. IL-6 blockade inhibits the induction of myelin antigen–specific TH17 cells and TH1 cells in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 105, 9041–9046 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Kabashima, K. et al. Prostaglandin E2–EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9, 744–749 (2003).
  Article CAS PubMed Google Scholar
• Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238 (2006).
  Article CAS PubMed Google Scholar
• Sheibanie, A.F. et al. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23 → IL-17 axis. J. Immunol. 178, 8138–8147 (2007).
  Article CAS PubMed Google Scholar
• Khayrullina, T., Yen, J.H., Jing, H. & Ganea, D. In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of TH17 cells. J. Immunol. 181, 721–735 (2008).
  Article CAS PubMed Google Scholar
• Nagamachi, M. et al. Facilitation of TH1-mediated immune response by prostaglandin E receptor EP1. J. Exp. Med. 204, 2865–2874 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Bos, J.L. Epac proteins: multi-purpose cAMP targets. Trends Biochem. Sci. 31, 680–686 (2006).
  Article CAS PubMed Google Scholar
• Libioulle, C. et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 3, e58 (2007).
  Article PubMed PubMed Central Google Scholar
• Neurath, M.F. IL-23: a master regulator in Crohn disease. Nat. Med. 13, 26–28 (2007).
  Article CAS PubMed Google Scholar
• Hervé, M. et al. Pivotal roles of the parasite PGD2 synthase and of the host D prostanoid receptor 1 in schistosome immune evasion. Eur. J. Immunol. 33, 2764–2772 (2003).
  Article PubMed Google Scholar
• Kabashima, K. et al. Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat. Immunol. 4, 694–701 (2003).
  Article CAS PubMed Google Scholar
• Chizzolini, C. et al. Prostaglandin E2 synergistically with interleukin-23 favors human TH17 expansion. Blood 112, 3696–3703 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Boniface, K. et al. Prostaglandin E2 regulates TH17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J. Exp. Med. 206, 535–548 (2009).
  Article CAS PubMed PubMed Central Google Scholar